A share price of Soleno Therapeutics Inc [SLNO] is currently trading at $66.81, down -1.88%. In order to assess the stock’s recent performance, you can check whether its short-term value is rising or falling. The SLNO shares have lost -19.85% over the last week, with a monthly amount drifted -23.18%, and not seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Soleno Therapeutics Inc [NASDAQ: SLNO] stock has seen the most recent analyst activity on June 23, 2025, when TD Cowen initiated its Buy rating and assigned the stock a price target of $110. On December 02, 2024, Stifel reiterated its Buy rating but maintained its price target of $74 on the stock. Robert W. Baird reiterated its Outperform rating but stick to its price target of $72 on December 02, 2024. H.C. Wainwright initiated its recommendation with a Buy and recommended $70 as its price target on September 03, 2024. Robert W. Baird started tracking with a Outperform rating for this stock on May 10, 2024, and assigned it a price target of $72. In a note dated February 05, 2024, Piper Sandler initiated an Overweight rating and provided a target price of $93 on this stock.
Soleno Therapeutics Inc experienced fluctuations in its stock price throughout the past year between $41.50 and $90.32. Currently, Wall Street analysts expect the stock to reach $102.33 within the next 12 months. Soleno Therapeutics Inc [NASDAQ: SLNO] shares were valued at $66.81 at the most recent close of the market. An investor can expect a potential return of 53.17% based on the average SLNO price forecast.
Analyzing the SLNO fundamentals
Gross Profit Margin for this corporation currently stands at 0.98% with Operating Profit Margin at -5.87%, Pretax Profit Margin comes in at -5.54%, and Net Profit Margin reading is -5.54%. To continue investigating profitability, this company’s Return on Assets is posted at -0.54, Equity is -0.74 and Total Capital is -0.62. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of0.22.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 66.10 points at the first support level, and at 65.38 for the second support level. However, for the 1st resistance point, the stock is sitting at 68.15, and for the 2nd resistance point, it is at 69.48.
Ratios To Look Out For
To put it in perspective, the Current Ratio for Soleno Therapeutics Inc [NASDAQ:SLNO] is 15.13. In addition, the Quick Ratio stands at 15.01 and the Cash Ratio stands at 3.65. Considering the valuation of this stock, the price to sales ratio is 108.71, the price to book ratio is 14.03.
Transactions by insiders
Recent insider trading involved Abingworth Bioventures VII LP, Shareholder, that happened on Aug 11 ’25 when 1.35 million shares were purchased. Hirano Patricia C completed a deal on Jul 01 ’25 to sell 3830.0 shares. Meanwhile, Officer PATRICIA HIRANO bought 3830.0 shares on Jul 01 ’25.
